[Translation] Phase Ib clinical study of tolerability, safety and pharmacokinetics of humanized hPV19 monoclonal antibody (anti-VEGF monoclonal antibody) injection combined with chemotherapy in patients with advanced malignant solid tumors
观察人源化hPV19单克隆抗体注射液(hPV19单抗)联合化疗给药的耐受性、安全性以及药代动力学;观察人源化hPV19单克隆抗体注射液联合化疗的初步疗效,为下一步临床研究提供依据,获得联合用药的最佳临床给药剂量和间隔。
[Translation] To observe the tolerance, safety and pharmacokinetics of humanized hPV19 monoclonal antibody injection (hPV19 monoclonal antibody) combined with chemotherapy; to observe the preliminary efficacy of humanized hPV19 monoclonal antibody injection combined with chemotherapy, for the following A further clinical study provides the basis for obtaining the optimal clinical administration dose and interval of the combination.